Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up. (Q48218348)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 October 2011

Language	Label	Description	Also known as
English	Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.	scientific article published on 29 October 2011

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

15

object named as

I Vergote

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

author name string

K Haest

1

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

A Kumar

2

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

B Van Calster

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

K Leunen

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

A Smeets

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

F Amant

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

P Berteloot

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

H Wildiers

8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

R Paridaens

9

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

E Van Limbergen

10

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

C Weltens

11

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

H Janssen

12

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

S Peeters

13

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

J Menten

14

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

B Morlion

16

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

J Verhaeghe

17

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

M R Christiaens

18

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

P Neven

19

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

publication date

29 October 2011

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

Annals of Oncology

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

23

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

1449-1454

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

The prevalence of menopausal symptoms in patients treated for breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Postmenopausal estrogen for treatment of hot flashes: clinical applications

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Hot flushes in breast cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Early discontinuation of tamoxifen: a lesson for oncologists.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Hot flashes: behavioral treatments, mechanisms, and relation to sleep

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Determinants of hot flashes and night sweats

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

LH, FSH and skin temperaure during the menopausal hot flash

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Stellate ganglion blockade provides relief from menopausal hot flashes: a case report series

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Updated findings on the effects of stellate-ganglion block on hot flushes and night awakenings.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Pilot evaluation of a stellate ganglion block for the treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

What can be done about hot flushes after treatment for breast cancer?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Methodologic lessons learned from hot flash studies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Estrogen regulation of neurotrophin expression in sympathetic neurons and vascular targets.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Phase III evaluation of fluoxetine for treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Management of menopausal symptoms in breast cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women--a multicenter randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Pulsed radiofrequency application in the treatment of chronic pain

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR478

21 January 2018

Identifiers

10.1093/ANNONC/MDR478

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

release_dpa7gdts5nhztlc34c7jkymciy

1 reference

https://api.fatcat.wiki/v0/release/dpa7gdts5nhztlc34c7jkymciy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/22039079

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48218348&oldid=1838700692"